Final answer:
The goal of nursing care for a client with acute myeloid leukemia (AML) is to prevent hemorrhage (option 4) due to the condition's impact on blood cell production. An AML patient would have impaired production of erythrocytes, and a neutrophil count of 1900 cells per microliter is generally considered sufficient to proceed with chemotherapy.
Step-by-step explanation:
The goal of nursing care for a client with acute myeloid leukemia (AML) is to prevent hemorrhage. AML is a type of cancer characterized by the overproduction of immature white blood cells in the bone marrow. These cells, known as blast cells, can crowd out the normal cells that manufacture red blood cells (erythrocytes), platelets, and mature white blood cells. As a result, AML patients often suffer from anemia due to reduced erythrocyte production, an increased risk of infection due to a lack of functional white blood cells, and an increased risk of bleeding due to a shortage of platelets.
To answer the schoolwork questions, a patient with acute myeloid leukemia would experience impaired production of erythrocytes. This occurs because the overproduction of leukemia cells in the bone marrow interferes with the production of normal blood cells, including erythrocytes, which are responsible for transporting oxygen throughout the body.
Regarding the absolute neutrophil count (ANC), a neutrophil count of 1900 cells per microliter is considered within the normal range, or only slightly below. For many institutions, an ANC above 1500 per microliter is acceptable for proceeding with chemotherapy. Therefore, the healthcare team would likely proceed with chemotherapy treatment because a count of 1900 cells per microliter indicates that the patient has a sufficient number of neutrophils to fight off infection during treatment. However, it is important to note that other factors may influence this decision, including the patient’s overall health, type and stage of cancer, and specific chemotherapy regimen.